These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8916122)
1. MIB-1 immunostaining and DNA flow cytometry in meningiomas. Yasue M; Akasaki Y; Numoto TR; Abe S; Abe T; Takeuchi Y; Tanaka J Noshuyo Byori; 1996 Apr; 13(1):17-20. PubMed ID: 8916122 [TBL] [Abstract][Full Text] [Related]
2. [DNA analysis of meningiomas using paraffin-embedded surgical specimens in connection with clinical recurrence]. Akachi K; Matsumoto M; Yasue M; Nakamura N; Kamada M; Ohno T No Shinkei Geka; 1991 Dec; 19(12):1129-34. PubMed ID: 1766537 [TBL] [Abstract][Full Text] [Related]
3. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen. Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573 [TBL] [Abstract][Full Text] [Related]
4. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry. Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919 [TBL] [Abstract][Full Text] [Related]
5. Clinico-pathological correlations in meningiomas: a DNA and immunohistochemical study. Cruz-Sánchez FF; Miquel R; Rossi ML; Figols J; Palacín A; Cardesa A Histol Histopathol; 1993 Jan; 8(1):1-8. PubMed ID: 8443419 [TBL] [Abstract][Full Text] [Related]
6. [P53 protein expression and proliferative potential in non-recurrent and recurrent meningiomas]. Miyagami M; Kanou T; Nakamura S No To Shinkei; 1996 Aug; 48(8):719-25. PubMed ID: 8797205 [TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Perry A; Stafford SL; Scheithauer BW; Suman VJ; Lohse CM Cancer; 1998 Jun; 82(11):2262-9. PubMed ID: 9610708 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of the proliferative potential of meningiomas with MIB-1 monoclonal antibodies]. Miyagami M; Shibuya T; Miyagi A; Tsubokawa T No To Shinkei; 1996 Jan; 48(1):39-43. PubMed ID: 8679317 [TBL] [Abstract][Full Text] [Related]
9. The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas. Lin YW; Tai SH; Huang YH; Chang CC; Juan WS; Chao LC; Wen MJ; Hung YC; Lee EJ Cytometry B Clin Cytom; 2015; 88(5):312-9. PubMed ID: 25408130 [TBL] [Abstract][Full Text] [Related]
10. DNA ploidy and cell-cycle analysis in intracranial meningiomas and hemangiopericytomas: a study with high-resolution DNA flow cytometry. Zellner A; Meixensberger J; Roggendorf W; Janka M; Hoehn H; Roosen K Int J Cancer; 1998 Apr; 79(2):116-20. PubMed ID: 9583723 [TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors. Linden MD; el-Naggar AK; Nathanson SD; Jacobson G; Zarbo RJ Mod Pathol; 1996 Jun; 9(6):682-9. PubMed ID: 8782208 [TBL] [Abstract][Full Text] [Related]
12. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231 [TBL] [Abstract][Full Text] [Related]
13. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine]. Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining for claudin-1 can help distinguish meningiomas from histologic mimics. Hahn HP; Bundock EA; Hornick JL Am J Clin Pathol; 2006 Feb; 125(2):203-8. PubMed ID: 16393681 [TBL] [Abstract][Full Text] [Related]
15. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence. Kunishio K; Ohmoto T; Matsuhisa T; Maeshiro T; Furuta T; Matsumoto K Cancer; 1994 Apr; 73(8):2200-5. PubMed ID: 8156526 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas. Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133 [TBL] [Abstract][Full Text] [Related]
17. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining. Ferraraccio F; Accardo M; Giangaspero F; Cuccurullo L Clin Neuropathol; 2003; 22(4):187-92. PubMed ID: 12908755 [TBL] [Abstract][Full Text] [Related]
18. The prediction of recurrence in meningiomas. A flow cytometric study of paraffin-embedded archival material. May PL; Broome JC; Lawry J; Buxton RA; Battersby RD J Neurosurg; 1989 Sep; 71(3):347-51. PubMed ID: 2769385 [TBL] [Abstract][Full Text] [Related]
19. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study. Abry E; Thomassen IØ; Salvesen ØO; Torp SH Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502 [TBL] [Abstract][Full Text] [Related]
20. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast. Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]